Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Item Type
      Item Type
      Clear All
      Item Type
  • Subject
      Subject
      Clear All
      Subject
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
      More Filters
      Clear All
      More Filters
      Source
    • Language
31 result(s) for "Whitley, Sa"
Sort by:
The Collective Come-Up: Black Queer Placemaking in Subprime Baltimore
The Collective Come-Up: Black Queer Placemaking in Subprime Baltimore engages the experiences, community organizing, and alternative economic frameworks of black queer and transgender women in the age of “credit-led accumulation” and neoliberal urban planning projects that stimulate the gentrification of black neighborhoods (Soederberg, 2013). This black feminist ethnography, situated within the overlapping geographies of urban renewal programs, subprime foreclosure, and speculative urbanism, foregrounds the contested place in black queer spatial imaginaries of private property in a city with 30,000 vacant properties and lots. Specifically, I examine Brioxy’s black land movement in West Baltimore–an effort that seeks to forestall gentrification and “keep the hood black.” From black placemaking to “putting a stake in the ground” against gentrification, I consider how black queer organizers figure the post-crisis financial and real estate markets as sites of both subjection and possibility. Provocatively, the collective puts forth a collectivized model of black private property ownership as opposition to structural processes of gentrification and black displacement. At the same time, they engage in what I call speculative social reproduction across black queer households to confront the antiblackness of speculative finance capitalism.As a critical intervention, this dissertation discloses the ongoing violence of liberal property and propertied citizenship by contesting contemporary constructions of the subprime foreclosure crisis itself. This project centers archives of effects overlooked in standard accounts, including the life and death of a black transgender woman killed in a vacant residential property. In dialogue with queer of color analyses of capitalism’s contradictions, I characterize Baltimore’s landscapes of subprime architectures and consider the ways that decades of urban renewal and foreclosure policies regulate black trans life and produce untimely death. Case studies of black queer and trans placemaking compel us to consider the ways that black queer and trans folx aim to variously appropriate, disassemble, refuse, or “disidentify” with property and “propertied citizenship” (Muñoz, 1999; Roy, 2003).
Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study
Respiratory syncytial virus is a common cause of illness and hospitalization, especially among infants and immunocompromised persons, but there are no accepted antiviral therapies. In this RSV challenge study, GS-5806, a new compound, showed activity against RSV. Respiratory syncytial virus (RSV) infection accounts for substantial morbidity and mortality among infants 1 – 7 and is the most common reason for hospitalization of infants in the United States, 8 with an even greater outpatient burden of disease. Estimates indicate that among children younger than 2 years of age, the annual rate of RSV-related hospitalization is 5.2 per 1000, the rate of emergency department encounters is 32 to 57 per 1000, and the rate of outpatient visits is 66 to 177 per 1000. 2 Among infants younger than 1 year of age, the risk of death from respiratory causes is increased by a . . .
236 Developing a Young Persons Advisory Group (YPAG) to inform the design of a study to improve pre-hospital pain management for Children and Young People (CYP)
BackgroundPatient and public involvement is an integral component of clinical research. A YPAG is group of young people with active involvement in the design and conduct of clinical research aimed at CYP.1 2 Active collaboration with a YPAG can be mutually beneficial and can have a positive impact on study design and conduct.2 3 We report on the involvement of young people, their influence on study design and the perceived benefits to members.MethodA UK secondary school was approached and ten 16–17 year old students agreed to form a YPAG. Three 1-hour sessions were planned involving arts-based activities to explore key challenges, predetermined iteratively by the research team. Activities involved group work to explore and propose solutions for effective CYP recruitment and data collection, produce a study logo and review the plain English summary.ResultsYPAG members produced insightful arts-based posters containing important ideas and concepts that were incorporated into the study design. A study logo was created, diaries and electronic communication methods to collect data were added and a variety of age-based leaflets were added to the recruitment strategy. Members reported several benefits from the sessions, including enhanced creative and problem-solving skills and members enjoyed the teamwork and collaborative approach.ConclusionYPAG involvement resulted in meaningful improvements to research design and members gained new knowledge, transferrable skills and improved confidence. This experience should help inform YPAG involvement in future research.ReferencesNational Institute for Health Research (2021) NIHR resource for public involvement - Involving children and young people as advisors in research. Available at: https://www.learningforinvolvement.org.uk/?opportunity=nihr-involving-children-and-young-people-as-advisors-in-research Accessed 06-Dec-2021Rouncefield-Swales A, Harris J, Carter B, Bray L, Bewley T, et al. (2021) Children and young people’s contributions to public involvement and engagement activities in health-related research: A scoping review. PLOS ONE 16(6): e0252774. https://doi.org/10.1371/journal.pone.0252774Abrehart N, Frost K, the Young Persons Advisory Group. et al. (2021) ‘A little (PPI) MAGIC can take you a long way’ : involving children and young people in research from inception of a novel medical device to multi-centre clinical trial Roald Dahl, James and the Giant Peach (1961). Res Involv Engagem 7, 2 https://doi.org/10.1186/s40900-020-00243-0.Conflict of interestGAW received funding to conduct this project through a post-doctoral bridging fellowship. HT, TB, EM and RT received financial compensation, in line with NIHR/INVOLVE guidelines, for their involvement in the YPAG group.FundingThis project formed part of a post-doctoral bridging fellowship supported by the National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC EM) and Health Education England. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.
Determining the longitudinal validity and meaningful differences in HRQL of the PedsQL™ Sickle Cell Disease Module
Background Detecting change in health status over time and ascertaining meaningful changes are critical elements when using health-related quality of life (HRQL) instruments to measure patient-centered outcomes. The PedsQL™ Sickle Cell Disease module, a disease specific HRQL instrument, has previously been shown to be valid and reliable. Our objectives were to determine the longitudinal validity of the PedsQL™ Sickle Cell Disease module and the change in HRQL that is meaningful to patients. Methods An ancillary study was conducted utilizing a multi-center prospective trial design. Children ages 4–21 years with sickle cell disease admitted to the hospital for an acute painful vaso-oclusive crisis were eligible. Children completed HRQL assessments at three time points (in the Emergency Department, one week post-discharge, and at return to baseline (One to three months post-discharge). The primary outcome was change in HRQL score. Both distribution (effect size, standard error of measurement (SEM)) and anchor (global change assessment) based methods were used to determine the longitudinal validity and meaningful change in HRQL. Changes in HRQL meaningful to patients were identified by anchoring the change scores to the patient’s perception of global improvement in pain. Results Moderate effect sizes (0.20–0.80) were determined for all domains except the Communication I and Cognitive Fatigue domains. The value of 1 SEM varied from 3.8–14.6 across all domains. Over 50% of patients improved by at least 1 SEM in Total HRQL score. A HRQL change score of 7–10 in the pain domains represented minimal perceived improvement in HRQL and a HRQL change score of 18 or greater represented moderate to large improvement. Conclusions The PedsQL™ Sickle Cell Disease Module is responsive to changes in HRQL in patients experiencing acute painful vaso-occlusive crises. The study data establish longitudinal validity and meaningful change parameters for the PedsQL™ Sickle Cell Disease Module. Trial Registration ClinicalTrials.gov (study identifier: NCT01197417 ). Date of registration: 08/30/2010
Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase
Pulmonary function is impaired in untreated mucopolysaccharidosis type VI (MPS VI). Pulmonary function was studied in patients during long-term enzyme replacement therapy (ERT) with recombinant human arylsulfatase B (rhASB; rhN-acetylgalactosamine 4-sulfatase). Pulmonary function tests prior to and for up to 240 weeks of weekly infusions of rhASB at 1 mg/kg were completed in 56 patients during Phase 1/2, Phase 2, Phase 3 and Phase 3 Extension trials of rhASB and the Survey Study. Forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1) and, in a subset of patients, maximum voluntary ventilation (MVV), were analyzed as absolute volume in liters. FEV1 and FVC showed little change from baseline during the first 24 weeks of ERT, but after 96 weeks, these parameters increased over baseline by 11% and 17%, respectively. This positive trend compared with baseline continued beyond 96 weeks of treatment. Improvements from baseline in pulmonary function occurred along with gains in height in the younger group (5.5% change) and in the older patient group (2.4% change) at 96 weeks. Changes in MVV occurred earlier within 24 weeks of treatment to approximately 15% over baseline. Model results based on data from all trials showed significant improvements in the rate of change in pulmonary function during 96 weeks on ERT, whereas little or no improvement was observed for the same time period prior to ERT. Thus, analysis of mean percent change data and longitudinal modeling both indicate that long-term ERT resulted in improvement in pulmonary function in MPS VI patients.